about us
Company
Transforming Oncology with Precision and AI-Driven Insights
GenoCure.AI is revolutionizing the landscape of oncology by harnessing the power of advanced AI and deep genomic analysis. Founded with a mission to personalize and optimize cancer treatment strategies, we provide physicians, healthcare providers, and pharmaceutical companies with actionable insights that enhance therapeutic efficacy and improve patient outcomes.
Our proprietary technology, Supreme™, enables a deeper understanding of tumor biology, empowering oncologists and researchers with precise, data-driven decision-making tools. By analyzing complex genomic interactions and leveraging AI-driven modeling, Supreme™ identifies treatment strategies tailored to each patient’s unique molecular profile.
our
story
Bridging the Gap Between
Science and Treatment
GenoCure.AI was founded by a multidisciplinary team of experts in medicine, artificial intelligence, and business strategy, driven by a shared vision: to bridge the gap between scientific discoveries and real-world clinical applications in oncology.
Our journey began with a fundamental question: How can we leverage AI to revolutionize precision oncology and improve treatment outcomes? Recognizing the challenges of treatment resistance and suboptimal therapeutic strategies, we developed an AI-powered approach to enhance clinical decision-making and optimize personalized treatments.
By collaborating with physicians, medical institutions, and pharmaceutical companies, we are shaping the future of precision medicine. Our goal is to enable a world where every cancer patient can receive the most effective treatment tailored to their unique molecular profile—an aspiration that drives our continuous innovation and research.
our
vision
Personalized Cancer Therapy,
Powered by AI
Through relentless innovation and collaboration, we strive to redefine the standards of precision oncology and bring hope to millions worldwide.
At GenoCure.AI, we envision a world where every cancer patient receives the right treatment at the right time. We are committed to:
Enhancing clinical decision-making:
Providing oncologists with real-time, AI-driven insights to personalize treatment strategies.
Empowering healthcare providers:
Equipping medical institutions with advanced tools to optimize patient outcomes.
Supporting pharmaceutical innovation:
Optimizing drug development pipelines and accelerating the identification of effective therapies.
meet
ouR team
At the heart of GenoCure.AI is a leadership team that brings together cutting-edge science, AI innovation, and strategic vision. Founded by Prof. Shai Rosenberg, Dr. Eitan Eliram, and Eitan Rubinow, the company thrives on the synergy of their diverse expertise.
Learn More
Join Us
on This Mission
We are continuously expanding our network of collaborators, from healthcare providers to research institutions and pharmaceutical companies. If you share our vision for AI-powered precision oncology and want to be part of this transformative journey, we invite you to connect with us.
Together, we can shape the future of cancer treatment.